CUE
Cue Biopharma, Inc.Company with tickers: CUE
CIK
1645460
CUSIP
22978P106
Shares Outstanding
4,045,701
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-05-03 | Lin Shao-Lee | Director | Award | 655,074 |
| 2026-05-03 | Lin Shao-Lee | Director | Award | 327,537 |
| 2026-04-30 | Lin Shao-Lee | Director | Other | 0 |
| 2026-04-09 | Sandercock Colin | SVP, GENERAL COUNSEL | Award | 200,000 |
| 2026-04-09 | Warren Lucinda | CHIEF BUSINESS OFFICER | Award | 250,000 |
| 2026-04-09 | Baker Daniel G. | Director | Award | 100,000 |
| 2026-01-02 | Morich Frank | Director | Award | 24,400 |
| 2026-01-02 | Verheyen Patrick | Director | Award | 24,400 |
| 2026-01-02 | Kiener Peter A | Director | Award | 24,400 |
| 2026-01-02 | Broadfoot Jill Marie | Chief Financial Officer | Award | 24,400 |
| 2026-01-02 | Garzone Pamela | Director | Award | 24,400 |
| 2026-01-02 | Sarraf Pasha | Director | Award | 24,400 |
| 2025-12-30 | Sarraf Pasha | Director | Buy | 77,417 |
| 2025-12-30 | Sarraf Pasha | Director | Buy | 4,229 |
| 2025-12-30 | Sarraf Pasha | Director | Buy | 78,116 |
| 2025-12-30 | Sarraf Pasha | Director | Buy | 77,148 |
| 2025-12-30 | Sarraf Pasha | Director | Buy | 86,947 |
| 2025-12-03 | Sandercock Colin | SVP, GENERAL COUNSEL | Award | 70,000 |
| 2025-09-29 | Warren Lucinda | CHIEF BUSINESS OFFICER | Award | 125,000 |
| 2025-09-29 | Baker Daniel G. | Director | Award | 50,000 |
| 2025-09-29 | Azam Usman | Director, CHIEF EXECUTIVE OFFICER | Award | 1,875,000 |
| 2025-09-29 | Azam Usman | Director, CHIEF EXECUTIVE OFFICER | Other | 0 |
| 2025-09-26 | Sandercock Colin | SVP, GENERAL COUNSEL | Award | 30,000 |
| 2025-06-04 | Broadfoot Jill Marie | Chief Financial Officer | Award | 48,800 |
| 2025-06-04 | Broadfoot Jill Marie | Chief Financial Officer | Other | 0 |
| 2025-03-21 | Baker Daniel G. | Director | Award | 100,000 |
| 2025-03-21 | Sandercock Colin | SVP, GENERAL COUNSEL | Award | 200,000 |
| 2025-03-21 | Warren Lucinda | CHIEF BUSINESS OFFICER | Award | 250,000 |
| 2025-03-21 | Millar Kerri-Ann | CHIEF FINANCIAL OFFICER | Award | 200,000 |
| 2025-03-21 | PASSERI DANIEL R | Director, CHIEF EXECUTIVE OFFICER | Award | 450,000 |
| 2025-03-21 | Levisetti Matteo | Chief Medical Officer | Award | 250,000 |
| 2025-03-10 | Sarraf Pasha | Director | Award | 48,800 |
| 2025-03-10 | Sarraf Pasha | Director | Other | 0 |
| 2025-01-02 | Morich Frank | Director | Award | 24,400 |
| 2025-01-02 | DRISCOLL FREDERICK W | Director | Award | 24,400 |
| 2025-01-02 | Verheyen Patrick | Director | Award | 24,400 |
| 2025-01-02 | Garzone Pamela | Director | Award | 24,400 |
| 2025-01-02 | Kiener Peter A | Director | Award | 24,400 |
| 2024-12-16 | PASSERI DANIEL R | Director, CHIEF EXECUTIVE OFFICER | Buy | 30,000 |
| 2024-11-25 | Baker Daniel G. | Director | Award | 200,000 |
| 2024-11-25 | Baker Daniel G. | Director | Other | 0 |
| 2024-09-03 | Warren Lucinda | CHIEF BUSINESS OFFICER | Award | 350,000 |
| 2024-09-03 | Warren Lucinda | CHIEF BUSINESS OFFICER | Other | 0 |
| 2024-06-05 | Fox Michael J | Director | Award | 48,800 |
| 2024-06-05 | Millar Kerri-Ann | CHIEF FINANCIAL OFFICER | Award | 60,000 |
| 2024-06-05 | Levisetti Matteo | Chief Medical Officer | Award | 125,000 |
| 2024-06-05 | Suri Anish | PRESIDENT AND CSO | Award | 150,000 |
| 2024-06-05 | Sandercock Colin | SVP, GENERAL COUNSEL | Award | 60,000 |
| 2024-06-05 | Fox Michael J | Director | Other | 100,000 |
| 2024-06-05 | Fox Michael J | Director | Other | 1,000,000 |
| 2024-03-06 | Suri Anish | PRESIDENT AND CSO | Award | 300,000 |
| 2024-03-06 | PASSERI DANIEL R | Director, CHIEF EXECUTIVE OFFICER | Award | 400,000 |
| 2024-03-06 | Sandercock Colin | SVP, GENERAL COUNSEL | Award | 175,000 |
| 2024-03-06 | Millar Kerri-Ann | CHIEF FINANCIAL OFFICER | Award | 250,000 |
| 2024-03-06 | Levisetti Matteo | Chief Medical Officer | Award | 260,000 |
| 2024-02-20 | Levisetti Matteo | Chief Medical Officer | Award | 25,000 |
| 2024-01-02 | Verheyen Patrick | Director | Award | 24,400 |
| 2024-01-02 | Garzone Pamela | Director | Award | 24,400 |
| 2024-01-02 | Kiener Peter A | Director | Award | 24,400 |
| 2024-01-02 | DRISCOLL FREDERICK W | Director | Award | 24,400 |
| 2024-01-02 | Morich Frank | Director | Award | 24,400 |
| 2023-08-25 | Suri Anish | PRESIDENT AND CSO | Buy | 4,000 |
| 2023-08-14 | PASSERI DANIEL R | Director, CHIEF EXECUTIVE OFFICER | Buy | 3,000 |
| 2023-07-21 | Levisetti Matteo | Chief Medical Officer | Award | 82,500 |
| 2023-07-21 | PASSERI DANIEL R | Director, CHIEF EXECUTIVE OFFICER | Award | 450,000 |
| 2023-07-21 | Suri Anish | PRESIDENT AND CSO | Award | 124,125 |
| 2023-07-21 | Millar Kerri-Ann | CHIEF FINANCIAL OFFICER | Award | 113,000 |
| 2023-07-21 | Sandercock Colin | SVP, GENERAL COUNSEL | Award | 75,000 |
| 2023-04-19 | Garzone Pamela | Director | Award | 40,000 |
| 2023-04-19 | Garzone Pamela | Director | Other | 0 |
| 2023-04-11 | Verheyen Patrick | Director | Other | 8,174 |
| 2023-04-11 | Verheyen Patrick | Director | Award | 40,000 |
| 2023-03-23 | Kiener Peter A | Director | Sell | 9,325 |
| 2023-03-23 | Kiener Peter A | Director | Convert | 9,682 |
| 2023-03-23 | Kiener Peter A | Director | Convert | 9,682 |
| 2023-02-16 | NASSHORN PATRICIA | Chief Business Officer | Award | 97,900 |
| 2023-02-16 | PASSERI DANIEL R | Director, CHIEF EXECUTIVE OFFICER | Award | 324,000 |
| 2023-02-16 | Millar Kerri-Ann | CHIEF FINANCIAL OFFICER | Award | 124,000 |
| 2023-02-16 | Suri Anish | PRESIDENT AND CSO | Award | 125,500 |
| 2023-02-16 | Sandercock Colin | SVP, GENERAL COUNSEL | Award | 100,000 |
| 2023-01-17 | Levisetti Matteo | Chief Medical Officer | Other | 0 |
| 2023-01-17 | Levisetti Matteo | Chief Medical Officer | Other | 9,230 |
| 2023-01-17 | Levisetti Matteo | Chief Medical Officer | Other | 0 |
| 2023-01-17 | Levisetti Matteo | Chief Medical Officer | Other | 0 |
| 2023-01-17 | Levisetti Matteo | Chief Medical Officer | Award | 110,000 |
| 2023-01-03 | Fletcher Aaron G.L. | 10% Owner | Award | 10,000 |
| 2023-01-03 | DRISCOLL FREDERICK W | Director | Award | 10,000 |
| 2023-01-03 | Morich Frank | Director | Award | 10,000 |
| 2023-01-03 | Kiener Peter A | Director | Award | 10,000 |
| 2023-01-03 | HOWSON TAMAR D | Director | Award | 10,000 |
| 2022-08-22 | Millar Kerri-Ann | CHIEF FINANCIAL OFFICER | Tax | 2,828 |
| 2022-08-21 | Millar Kerri-Ann | CHIEF FINANCIAL OFFICER | Convert | 6,667 |
| 2022-08-21 | Millar Kerri-Ann | CHIEF FINANCIAL OFFICER | Convert | 6,667 |
| 2022-06-14 | Gray Cameron | Director | Exercise | 61,111 |
| 2022-06-14 | Gray Cameron | Director | Tax | 51,562 |
| 2022-06-14 | Gray Cameron | Director | Exercise | 61,111 |
| 2022-05-27 | Morich Frank | Director | Buy | 28,000 |
| 2022-05-24 | Fletcher Aaron G.L. | 10% Owner | Buy | 55,000 |
| 2022-05-23 | Fletcher Aaron G.L. | 10% Owner | Other | 8,867 |
| 2022-05-23 | Fletcher Aaron G.L. | 10% Owner | Other | 165,000 |